• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 782-786.DOI: 10.3969/j.issn.1671-2587.2026.05.017

Previous Articles     Next Articles

Therapeutic Whole Blood Exchange for Propanil-Induced Methemoglobinemia after Methylene Blue Reached the Maximum Safe Cumulative Dose: A Case Report

XIAO Kun1, LIAO Yulong2, YU Pei2, LIU Jun2, HUANG Mengzhen2, XIAO Fei3, ZENG Jiaqi3, FAN Qin3, YANG Nan3, LE Aiping1   

  1. 1Department of Transfusion Medicine, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, 330006;
    2Department of Intensive Care Unit, Ganjiang New Area People's Hospital, Nanchang 330029;
    3Department of Transfusion Medicine, Ganjiang New Area People's Hospital, Nanchang 330029
  • Received:2026-09-02 Revised:2026-09-30 Online:2026-10-20 Published:2026-11-11

Abstract: We report a case of therapeutic whole blood exchange (TBE) for propanil-induced methemoglobinemia (MetHb) after the cumulative dose of methylene blue (MB) exceeded the recommended limit. The patient was a 50-year-old woman who received a cumulative MB dose of approximately 8 mg/kg, exceeding the recommended cumulative limit of 7 mg/kg. Although MetHb decreased from 17.8% to 5.5%, she remained comatose and cyanotic. Given the risk of paradoxical worsening of methemoglobinemia and hemolysis with further MB, additional dosing was withheld following multidisciplinary consultation, and TBE was performed. In this case, TBE consisted of therapeutic plasma exchange (TPE) followed by red blood cell exchange (RBCX) within one continuous treatment session to remove and replace both plasma and red blood cells. MetHb was 3.6% during TBE, 4.4% at 1 and 12 hours after TBE, 2.0% at 21 hours, and 0.5% at 36 hours. Intraoperative SpO2 increased to 97%~98%. The patient regained consciousness and was extubated at 24 hours after TBE. Vital signs remained stable during the procedure, and no serious transfusion-related adverse reactions occurred. This case suggests that TBE may be considered as an individualized rescue regimen when further MB administration is limited by safety concerns and severe clinical manifestations persist. Because MB had already substantially reduced MetHb and the patient concurrently received mechanical ventilation and other supportive treatments, the independent efficacy of TBE cannot be established from this case. Further cases are needed to clarify its indications, exchange dose, and safety.

Key words: Propanil poisoning, Methemoglobinemia, Methylene blue, Therapeutic whole blood exchange, Multidisciplinary team

CLC Number: